1.
Product Overview
2.
Research Methodology
3. Executive Summary
4. Voice of Customer
5. Global Nuclear
Medicine Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value &
Volume
5.2.
Market Share & Forecast
5.2.1. By Therapy (Radioactive
Iodine, Radioactive Antibodies, Radioactive Phosphorus, Others
5.2.2. By Type (SPECT
(Single photo emission computed tomography), PET (Positron emission tomography))
5.2.3. By Application (Cardiology, Respiratory, Orthopaedics, Neurology, Oncology,
Urology)
5.2.4. By Therapeutics (Alpha Particle Emitters, Beta Particle Emitters, Auger Electron Emitters)
5.2.5. By Route of Administration (Oral, Intravenous, Nasal)
5.2.6. By End-User (Hospitals,
Diagnostic centers, Others)
5.2.7. By Company (2019)
5.2.8. By Region
5.3. Market Attractiveness Index
6. Asia-Pacific Nuclear
Medicine Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value &
Volume
6.2.
Market Share & Forecast
6.2.1. By Therapy
6.2.2. By Type
6.2.3. By Application
6.2.4. By Therapeutics
6.2.5. By Route of Administration
6.2.6. By End-User
6.2.7. By Country
6.3.
Market Attractiveness Index
6.4.
Asia-Pacific: Country Analysis
6.4.1. China Nuclear
Medicine Market Outlook
6.4.1.1.
Market Size & Forecast
6.4.1.1.1.
By Value
6.4.1.2.
Market Share & Forecast
6.4.1.2.1.
By Therapy
6.4.1.2.2.
By Type
6.4.1.2.3.
By Application
6.4.1.2.4.
By Therapeutics
6.4.1.2.5.
By Route of Administration
6.4.1.2.6.
By End-User
6.4.2. India Nuclear
Medicine Market Outlook
6.4.2.1.
Market Size & Forecast
6.4.2.1.1.
By Value
6.4.2.2.
Market Share & Forecast
6.4.2.2.1.
By Therapy
6.4.2.2.2.
By Type
6.4.2.2.3.
By Application
6.4.2.2.4.
By Therapeutics
6.4.2.2.5.
By Route of Administration
6.4.2.2.6.
By End-User
6.4.3. Japan Nuclear
Medicine Market Outlook
6.4.3.1.
Market Size & Forecast
6.4.3.1.1.
By Value
6.4.3.2.
Market Share & Forecast
6.4.3.2.1.
By Therapy
6.4.3.2.2.
By Type
6.4.3.2.3.
By Application
6.4.3.2.4.
By Therapeutics
6.4.3.2.5.
By Route of Administration
6.4.3.2.6.
By End-User
6.4.4. South Korea Nuclear
Medicine Market Outlook
6.4.4.1.
Market Size & Forecast
6.4.4.1.1.
By Value
6.4.4.2.
Market Share & Forecast
6.4.4.2.1.
By Therapy
6.4.4.2.2.
By Type
6.4.4.2.3.
By Application
6.4.4.2.4.
By Therapeutics
6.4.4.2.5.
By Route of Administration
6.4.4.2.6.
By End-User
6.4.5. Singapore Nuclear
Medicine Market Outlook
6.4.5.1.
Market Size & Forecast
6.4.5.1.1.
By Value
6.4.5.2.
Market Share & Forecast
6.4.5.2.1.
By Therapy
6.4.5.2.2.
By Type
6.4.5.2.3.
By Application
6.4.5.2.4.
By Therapeutics
6.4.5.2.5.
By Route of Administration
6.4.5.2.6.
By End-User
6.4.6. Australia Nuclear
Medicine Market Outlook
6.4.6.1.
Market Size & Forecast
6.4.6.1.1.
By Value
6.4.6.2.
Market Share & Forecast
6.4.6.2.1.
By Therapy
6.4.6.2.2.
By Type
6.4.6.2.3.
By Application
6.4.6.2.4.
By Therapeutics
6.4.6.2.5.
By Route of Administration
6.4.6.2.6.
By End-User
7. Europe Nuclear
Medicine Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value &
Volume
7.2.
Market Share & Forecast
7.2.1. By Therapy
7.2.2. By Type
7.2.3. By Application
7.2.4. By Therapeutics
7.2.5. By Route of Administration
7.2.6. By End-User
7.2.7. By Country
7.3.
Market Attractiveness Index
7.4.
Europe: Country Analysis
7.4.1. France Nuclear
Medicine Market Outlook
7.4.1.1.
Market Size & Forecast
7.4.1.1.1.
By Value
7.4.1.2.
Market Share & Forecast
7.4.1.2.1.
By Therapy
7.4.1.2.2.
By Type
7.4.1.2.3.
By Application
7.4.1.2.4.
By Therapeutics
7.4.1.2.5.
By Route of Administration
7.4.1.2.6.
By End-User
7.4.2. Germany Nuclear
Medicine Market Outlook
7.4.2.1.
Market Size & Forecast
7.4.2.1.1.
By Value
7.4.2.2.
Market Share & Forecast
7.4.2.2.1.
By Therapy
7.4.2.2.2.
By Type
7.4.2.2.3.
By Application
7.4.2.2.4.
By Therapeutics
7.4.2.2.5.
By Route of Administration
7.4.2.2.6.
By End-User
7.4.3. United Kingdom
Nuclear Medicine Market Outlook
7.4.3.1.
Market Size & Forecast
7.4.3.1.1.
By Value
7.4.3.2.
Market Share & Forecast
7.4.3.2.1.
By Therapy
7.4.3.2.2.
By Type
7.4.3.2.3.
By Application
7.4.3.2.4.
By Therapeutics
7.4.3.2.5.
By Route of Administration
7.4.3.2.6.
By End-User
7.4.4. Italy Nuclear
Medicine Market Outlook
7.4.4.1.
Market Size & Forecast
7.4.4.1.1.
By Value
7.4.4.2.
Market Share & Forecast
7.4.4.2.1.
By Therapy
7.4.4.2.2.
By Type
7.4.4.2.3.
By Application
7.4.4.2.4.
By Therapeutics
7.4.4.2.5.
By Route of Administration
7.4.4.2.6.
By End-User
7.4.5. Russia Nuclear
Medicine Market Outlook
7.4.5.1.
Market Size & Forecast
7.4.5.1.1.
By Value
7.4.5.2.
Market Share & Forecast
7.4.5.2.1.
By Therapy
7.4.5.2.2.
By Type
7.4.5.2.3.
By Application
7.4.5.2.4.
By Therapeutics
7.4.5.2.5.
By Route of Administration
7.4.5.2.6.
By End-User
7.4.6. Spain Nuclear
Medicine Market Outlook
7.4.6.1.
Market Size & Forecast
7.4.6.1.1.
By Value
7.4.6.2.
Market Share & Forecast
7.4.6.2.1.
By Therapy
7.4.6.2.2.
By Type
7.4.6.2.3.
By Application
7.4.6.2.4.
By Therapeutics
7.4.6.2.5.
By Route of Administration
7.4.6.2.6.
By End-User
8. North America Nuclear
Medicine Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value &
Volume
8.2.
Market Share & Forecast
8.2.1. By Therapy
8.2.2. By Type
8.2.3. By Application
8.2.4. By Therapeutics
8.2.5. By Route of Administration
8.2.6. By End-User
8.2.7. By Country
8.3.
Market Attractiveness Index
8.4.
North America: Country Analysis
8.4.1. United States Nuclear
Medicine Market Outlook
8.4.1.1.
Market Size & Forecast
8.4.1.1.1.
By Value
8.4.1.2.
Market Share & Forecast
8.4.1.2.1.
By Therapy
8.4.1.2.2.
By Type
8.4.1.2.3.
By Application
8.4.1.2.4.
By Therapeutics
8.4.1.2.5.
By Route of Administration
8.4.1.2.6.
By End-User
8.4.2. Mexico Nuclear
Medicine Market Outlook
8.4.2.1.
Market Size & Forecast
8.4.2.1.1.
By Value
8.4.2.2.
Market Share & Forecast
8.4.2.2.1.
By Therapy
8.4.2.2.2.
By Type
8.4.2.2.3.
By Application
8.4.2.2.4.
By Therapeutics
8.4.2.2.5.
By Route of Administration
8.4.2.2.6.
By End-User
8.4.3. Canada Nuclear
Medicine Market Outlook
8.4.3.1.
Market Size & Forecast
8.4.3.1.1.
By Value
8.4.3.2.
Market Share & Forecast
8.4.3.2.1.
By Therapy
8.4.3.2.2.
By Type
8.4.3.2.3.
By Application
8.4.3.2.4.
By Therapeutics
8.4.3.2.5.
By Route of Administration
8.4.3.2.6.
By End-User
9. South America Nuclear
Medicine Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value &
Volume
9.2.
Market Share & Forecast
9.2.1. By Therapy
9.2.2. By Type
9.2.3. By Application
9.2.4. By Therapeutics
9.2.5. By Route of Administration
9.2.6. By End-User
9.2.7. By Country
9.3.
Market Attractiveness Index
9.4.
South America: Country Analysis
9.4.1. Brazil Nuclear
Medicine Market Outlook
9.4.1.1.
Market Size & Forecast
9.4.1.1.1.
By Value
9.4.1.2.
Market Share & Forecast
9.4.1.2.1.
By Therapy
9.4.1.2.2.
By Type
9.4.1.2.3.
By Application
9.4.1.2.4.
By Therapeutics
9.4.1.2.5.
By Route of Administration
9.4.1.2.6.
By End-User
9.4.2. Argentina Nuclear
Medicine Market Outlook
9.4.2.1.
Market Size & Forecast
9.4.2.1.1.
By Value
9.4.2.2.
Market Share & Forecast
9.4.2.2.1.
By Therapy
9.4.2.2.2.
By Type
9.4.2.2.3.
By Application
9.4.2.2.4.
By Therapeutics
9.4.2.2.5.
By Route of Administration
9.4.2.2.6.
By End-User
9.4.3. Colombia Nuclear
Medicine Market Outlook
9.4.3.1.
Market Size & Forecast
9.4.3.1.1.
By Value
9.4.3.2.
Market Share & Forecast
9.4.3.2.1.
By Therapy
9.4.3.2.2.
By Type
9.4.3.2.3.
By Application
9.4.3.2.4.
By Therapeutics
9.4.3.2.5.
By Route of Administration
9.4.3.2.6.
By End-User
10. Middle East and
Africa Nuclear Medicine Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value &
Volume
10.2.
Market Share & Forecast
10.2.1. By Therapy
10.2.2. By Type
10.2.3. By Application
10.2.4. By Therapeutics
10.2.5. By Route of Administration
10.2.6. By End-User
10.2.7. By Country
10.3.
Market Attractiveness Index
10.4.
MEA: Country Analysis
10.4.1. South Africa Nuclear
Medicine Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1.
By Value
10.4.1.2. Market Share & Forecast
10.4.1.2.1.
By Therapy
10.4.1.2.2.
By Type
10.4.1.2.3.
By Application
10.4.1.2.4.
By Therapeutics
10.4.1.2.5.
By Route of Administration
10.4.1.2.6.
By End-User
10.4.2. Saudi Arabia Nuclear
Medicine Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1.
By Value
10.4.2.2. Market Share & Forecast
10.4.2.2.1.
By Therapy
10.4.2.2.2.
By Type
10.4.2.2.3.